Last reviewed · How we verify

NCT04094259: Alter-MAI

Alternative Care in Patients With Auto-Immune Diseases

Completed Last updated 27 March 2026
What this trial tests

trial testing Questionnaire. in Auto-Immune Diseases in 121 participants. Completed in 1 December 2021.

Timeline
9 September 2019
Primary endpoint
1 December 2021
1 December 2021

Quick facts

Lead sponsorUniversity Hospital, Limoges
StatusCompleted
Study typeOBSERVATIONAL
Enrollment121
Start date9 September 2019
Primary completion1 December 2021
Estimated completion1 December 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Limoges

Who can join

18 and older, any sex, with Auto-Immune Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients followed in Internal Medicine bring together favorable conditions for the use of alternative medicines. While some are recognized for their benefits, some can, on the contrary, harm the patient. It is therefore proposed to make a complete descriptive inventory of these practices, through an anonymized questionnaire. The main objective is the evaluation of the proportion of the use of alternative medicines in patients with in the department of Internal Medicine A

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Limoges trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04094259.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing